| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a421ab71bd49a451d0a49d23a082c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-918 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb11faa369605a5baca4c7cd3a6a6203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe8814beba9f305304453202f3dbad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7062b038968fd093d313f4947488be5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464bc6397ac7b4309260c6e5b4014d26 |
| publicationDate |
2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014220613-A1 |
| titleOfInvention |
Cancer phospholipidome |
| abstract |
In general, the present invention relates to identification of lipidome biomarkers for cancer analysis and it provides prognostic and predictive methods and kits for cancer diagnosis and subtyping and for diagnosing and/or predicting the evolution of a tumor and its response to lipid metabolism-targeted or other types of therapy in a subject, by making use of phospholipid (PL) profiling, wherein changes in the combined acyl chain length of intact body fluid-derived or tumor-derived phospholipid species is indicative of an elongation phenotype. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018246112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102156217-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116027041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163581-A1 |
| priorityDate |
2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |